- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2014
- Public Summary Document (PSD) July 2014 PBAC Meeting - PDF
- Public Summary Document (PSD) July 2014 PBAC Meeting - Word
Umeclidinium bromide with vilanterol trifenatate – July 2014
UMECLIDINIUM+VILANTEROL, umeclidinium (as bromide) 62.5 microgram/actuation + vilanterol (as trifenatate) 25 microgram/actuation inhalation: powder for, 30 actuations, Anoro® Ellipta®, GlaxoSmithKline Australia Pty Ltd
Last updated
8 November 2023